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The effect of ischemia on phosphatidylinositol (PI) degrading enzymes in brain homogenate, cytosol and 
synaptosomes was investigated to evaluate the involvement of cholinergic receptor in PI hydrolysis during 
ischemia. The activity of phospholipase C in cytosol was not changed by ischemic insult. PI degradation 
in synaptosomes was significantly (60%) enhanced by &hernia. Atropine and y-butyrolactone abolished the 
ischemic effect on PI degradation, suggesting that the cholinergic receptor system mediates breakdown of 
PI during ischemia. 
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1. INTRODUCTION 
A major pathway of phosphatidylinositol (PI) 
degradation in animal tissues follows the 
phospholipase C route. In the nervous system 
evidence is available for both pathways: deacyla- 
tion by the action of phospholipase(s) A followed 
by lysophospholipase with glycerophosphoinositol 
(GPI) and fatty acids being formed [1,2], and 
phospholipase C (PhLC) [3] generating diacyl- 
glycerol (DG) and inositol monophosphate (IP). 
However, under normal conditions PI is not 
present in a form suitable to be attacked by 
phospholipase C. It is postulated that under resting 
conditions three factors may be involved in keep- 
ing PI protected: physiological concentration of 
K+ and Mg2+, positively charged proteins, and 
choline containing phospholipids (phosphatidyl- 
choline and sphingomyelin). In contrast, acidic 
phospholipids are activators of PhLC [4]. Thus, 
cell activation may result in membrane rearrange- 
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ment that makes degradation of PI possible. The 
phospholipase C action is specific for hydrolysis of 
diacyl GPI, and its action is phospholipid- and 
Ca2+-dependent [5]. The specificity of phospho- 
lipase AZ, which releases arachidonate from 
stearoyl-, arachidonyl-GPI is still problematic. 
It is known from our previous study [6,7], that 
ischemia leads to polyphosphoinositide degrada- 
tion and increases that of diacylglycerols by about 
30%. Concomitantly, water-soluble inositol 
metabolites such as IP are increased. The question 
was if these changes are also produced by 
ischemically induced PI degradation, and if the 
cholinergic receptor system is involved in the effect 
of ischemia on PI hydrolysis. For this reason the 
effect of global ischemia on PI degrading enzymes 
in brain homogenate, cytosol, and synaptosomes 
was investigated. The action of atropine and y- 
butyrolactone on ischemically induced changes 
was also evaluated. A preliminary report has 
already appeared in [8]. 
2. MATERIALS AND METHODS 
2.1. Cerebral ischemia 
Gerbils (Meriones unguiculates) of 50-70 g 
body wt were fed on a normal diet with water ad 
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libitum. Ischemia of the cerebral hemispheres was 
produced by bilateral ligation of the common 
carotid arteries for 10 min in the midcervical 
region through a midline incision under light 
diethyl ether anesthesia. Atropine in a dose of 
100 mg/kg body wt and y-butyrolactone (GBL) 
300 mg/kg body wt were injected intraperitoneally 
10 min before ischemic insult. Sham-operated 
animals served as a control. 
2.2. Preparation of synaptosomes and cytosol 
The fraction enriched in synaptic endings was 
isolated by the method of Booth and Clark [9]. 
Dissected brain hemispheres were homogenized in 
a Dounce-type glass homogenizer in ice cold isola- 
tion medium, containing 0.32 M source, 10 mM 
Tris-HCI buffer, pH 7.4, and 0.1 mM EDTA. The 
homogenate (10% w/v) was centrifuged for 3 min 
at 1100 x g. The resulting supernatant was cen- 
trifuged for 10 min at 17000 x g to yield a crude 
mitochondrial fraction. The crude mitochondrial 
fraction was resuspended in 10 ml of 12% Ficoll, 
and placed on the bottom of the centrifuge tube. 
Then, 5 ml of 7% Ficoll and 5 ml of isolation 
medium (0.32 M sucrose, 10 mM Tris-HCl, pH 
7.4, and 0.1 mM EDTA) were placed on the top 
and centrifuged for 30 min at 99000 x g. The 
material at the 12-7(rlo Ficoll interphase was col- 
lected, diluted 4 times with isolation medium, and 
centrifuged for 10 min at 17000 x g. The final 
synaptosomal pellet was resuspended and used for 
experiments. To obtain cytosol, the postmitochon- 
drial supernatant was centrifuged for 1 h at 
100000 x g. 
2.3. Preparation of labeled PI 
Young rats of 80-100 g body wt were injected 
intracerebrally with 4 ,Ki of myo-[3H]inositol, 
16 h prior to decapitation. After decapitation 
brains were quickly removed. Each brain was 
homogenized in 10 ml of 0.32 M sucrose with 
50 mM Tris-HCl, pH 7.4, and 1 mM EDTA, and 
extracted with 4 vols of chloroform/methanol 
(2: 1, v/v) according to Folch et al. [IO], vortexed 
several times, and centrifuged at 1100 x g for 
10 min for better separation of the water and 
organic phases. The lower phase was evaporated, 
and the lipids were dissolved in a small volume of 
chloroform/methanol (2: 1). The lipids were put 
on the thin layer chromatography plates and 
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Table 1 
Effect of ischemia on PI degradation i brain subcellular 
fractions 
Phosphatidyl-[3H]inositol 
hydrolyzed 
Cytosol Synaptosomes 
Control 31.51 f 3.71 4.11 + 0.57 
Ischemia 29.31 rt 4.06 6.93 + 1.15 
The radioactivity of PI was measured. The results are 
expressed in nmol of PI hydrolyzed per mg protein 
during 30 min. The results are means k SD from 3-4 
experiments performed in triplicate. The value that is 
significantly different from control by Student’s f-test is 
marked p < 0.05 
2mr 
Homogenate Synoptosomes 
Fig.1. Effect of ischemia on PI hydrolysis in brain 
homogenate and subcellular fractions. The radioactivity 
of hydrolyzed PI was measured in control and ischemic 
samples and the results for ischemia were expressed as a 
percentage of the control. The control value of PI 
hydrolyzed calculated as nmol/mg protein per 30 min 
was 16.29, 31.51, 4.11 for homogenate, cytosol and 
synaptosomes, respectively. SD was lo-15% of mean 
value. The results are means + SD from 3-4 experiments 
performed in triplicate. 
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developed in a solvent system of chloroform/ 
methanol/l6 N NHdOH/H20 (130:65:7.5:2.5, 
v/v). The gel between the origin and phosphatidyl- 
choline was scraped off and phospholipids were 
extracted two times with chloroform/methanol 
(2 : 1). Part of the extract was collected for analysis 
using two-dimensional thin layer chromatography 
and specific radioactivity of PI was 2.5 x 
lo5 dpm/pmol. 
2.4. Assay of PI breakdown 
The enzyme source (1 mg protein of 
homogenate, cytosol or synaptosomes) was in- 
cubated with 20-50 nmol of labeled PI substrate 
in 10 mM Tris-HCl buffer, pH 7.8, in the absence 
or presence of 0.1% deoxycholate, 2 mM CaC12 
and 10 mM LiCl. The incubation was carried out 
at 37°C for 30 min and was terminated with 
chloroform/methanol (2: 1). 0.5 ml portions of 
aqueous phase and total organic phase were taken 
separately for determination of radioactivity in a 
Beckman scintillation counter, LS 9000. 
2.5. Separation of water-soluble metabolites of 
inositol 
The water-soluble inositol metabolites in the 
Folch upper phase were applied to a small column 
(0.5-7.0 cm) containing 0.4 g Dowex AC 1 x 4 
200-400 mesh formate form, Biorad. Free in- 
ositol, glycerophosphoinositol and inositol 
monophosphate were eluted sequentially according 
to the procedure described by Berridge et al. [l 11. 
3. RESULTS 
The specific activity of phospholipase C in brain 
cytosol measured in the presence of labeled PI was 
3 1.51 + 3.74 nmol/mg protein per 30 min. The ac- 
tivity of PI degrading enzymes in synaptosomes 
was 4.11 + 0.53 nmol/mg protein per 30 min and 
was not changed after membrane washing pro- 
cedure. Synaptosome pellet was washed by 
resuspending the membranes in 0.32 M sucrose 
with 10 mM Tris-HCl, pH 7.4, and recentrifuged. 
The procedure was repeated 3 times (not shown). 
The degradation of PI was determined by 
measuring the radioactivity of PI and con- 
comitantly that of inositol monophosphate in the 
Folch upper phase after its separation on ion- 
exchange column chromatography. The results in- 
dicated that ischemia activates exclusively PI 
hydrolysis in synaptosomes by about 60%, but re- 
mained without effect on PI hydrolysis in the 
homogenate and in the cytosol (table 1, fig.1). 
The simultaneous analysis of radioactivity in PI 
from the Folch lower phase and analysis of water- 
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Fig.2. Effect of ischemia on PI hydrolysis and inositol monophosphate accumulation i  brain synaptosomes. Incubation 
mixture contained additionally 10 mM LiCI. The results are means f SD from 3-4 experiments performed in triplicate. 
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soluble inositol metabolites in the Folch upper 
phase provided evidence that ischemia activates 
phospholipase C rather than phospholipase(s) A in 
brain synaptosomes (fig.2). There was significantly 
higher accumulation of inositol monophosphate 
(about 60-70%) in ischemic synaptosomes (fig.2) 
with no detectable changes in GPI radioactivity 
(the radioactivity was too low for precise quan- 
! 
A 0 
Fig.3. Effect of atropine and y-butyrolactone on 
ischemically induced PI hydrolysis in brain 
synaptosomes. The radioactivity of hydrolyzed PI was 
determined. All the results were expressed as a 
percentage of the control value, untreated, sham- 
operated animals were used as controls. The control 
value of PI hydrolyzed calculated as dpm/mg protein 
per 30 min was 1082 + 145. The result is a mean value k 
SD from 4 experiments performed in triplicate. A, Sham 
operated group; II, animals pretreated with y- 
butyrolactone; III, animals pretreated with atropine. 
Pretreatment was done 10 min before sham operation. 
10 min after the operation, the animals were decapitated 
and synaptosomes were isolated. Details described in 
section 2. B, Ischemic group; I, animals without any 
pretreatment; II, animals pretreated with y- 
butyrolactone; III, animals pretreated with atropine. 
Pretreatment was carried out 10 min before ischemia. 
After 10 min of ischemic insult animals were decapitated 
and synaptosomes were isolated. The results are 
means rt SD from 3-4 experiments performed in 
triplicate. 
tification). When animals were pretreated with 
atropine before ischemia there was no activation of 
PI hydrolysis by synaptosomal enzymes (fig.3). 
y-Butyrolactone applied prior to ischemia also 
diminished the PI degradation by synaptosomes 
isolated from the animals submitted to ischemia 
(fig.3). 
4. DISCUSSION 
A wide variety of neurotransmitters, hormones 
and other biologically active substances timulate 
the turnover of PI through a receptor-mediated ac- 
tivation of phospholipase C [12-151. Our results 
indicate that during brain ischemia there is also ac- 
tivation of PI degradation exclusively by synap- 
tosomal enzymes. The cholinergic receptor system 
seems to be involved in the activation of enzymes 
degrading PI by ischemia but our results do not ex- 
clude the involvement of other receptors. The 
higher degradation of PI by synaptosomal en- 
zymes isolated from ischemic brain together with 
our previous findings on polyphosphoinositide 
depletion located in synaptosomes [6] may indicate 
the involvement of all three inositol phospholipids 
in disturbances of signal transduction occurring in 
the brain during and after ischemia. The nerve en- 
dings isolated as synaptosomes are relatively rich 
in inositol phospholipids. About 80% of the total 
inositol phospholipid pool contain arachidonyl- 
stearyl-PI species with high metabolic turnover 
[ 161. The involvement of muscarinic cholinergic 
receptor in the alteration of cerebral cortex myo- 
inositol and IP levels was described by Allison et 
al. [ 17,181. These results indicated that stimulation 
of the cholinergic receptor system may be involved 
in the activation of PI breakdown in the brain in- 
duced by ischemic insult. There was no stimulation 
of PI hydrolysis by synaptosomes isolated from 
the animals pretreated with atropine prior to 
ischemia. These results provide some evidence that 
degradation of not only PI-4,5_bisphosphate, but 
PI as well, may be coupled to the receptor stimula- 
tion during ischemia. 
The protective action of y-butyrolactone on PI 
hydrolysis may be related to its inhibitory effect on 
the cholinergic system. y-Butyrolactone ad- 
ministered in anesthetic doses increases the level of 
acetylcholine and causes cessation of impulse flow 
in the cholinergic pathway [ 191. Simultaneously 
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this naturally occurring brain metabolite affects 
the level of dopamine and the nigrostriatal impulse 
pathway. 
The activation of PI degradation by 
phospholipase C during ischemia may also be in- 
duced by the action of other neurotransmitter(s) 
on the receptors, by depolarization produced by 
ischemia, or by elevation of intracellular Ca2+. 
In conclusion: the degradation of a metabolical- 
ly active pool of PI may influence the level of 
diacylglycerol, free fatty acids and inositol 
phosphates in the brain during ischemia. This 
enhanced degradation of PI may subsequently 
result in higher prostaglandin and other eicosanoid 
production and promotion of membrane fusion in 
synaptosomes [20,21]. 
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